FDA NDC Directory · JSON-LD · Markdown

Orilissa

NDC 0074-0039 · HUMAN PRESCRIPTION DRUG · TABLET, FILM COATED

Generic nameElagolix
Labeler / ManufacturerAbbVie Inc.
Marketing categoryNew Drug Application (innovator) · App NDA210450
Dosage form / routeTABLET, FILM COATED · ORAL
Active ingredientsELAGOLIX SODIUM (200 mg/1)
Marketing started20180723
Package count2

External sources

Source: openFDA. Public-domain (CC0).